Geneva
Executive Summary
Novartis generic division acquires Invamed Dec.8. Invamed has been renamed the Geneva Pharmaceuticals Technology Corporation and will continue to operate under existing management, headed by President Ashok Patel. Invamed's distribution agreement with Apothecon for selected products, including generic warfarin, will be honored "through the respective contract periods"